Showing results (81-90 of 395) with videos related to
Sort By:
Pageof 40
The British Journal of Ophthalmology|July 9, 1999
Human retina contains polyamine sensitive [3H]-ifenprodil binding sites: implications for neuroprotection?N A Sharif, S X XuBritish Journal of Pharmacology|August 22, 2000
Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptorT L Davis, N A SharifJournal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 2, 2010
Platelet-activating factor-induced intracellular signaling and release of cytokines and prostaglandin E2 in immortalized human corneal epithelial cellsNajam A Sharif, Terry K WiernasMedical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|February 6, 2010
Polymorphisms in NOS3, ACE and PAI-1 genes and risk of spontaneous recurrent miscarriage in the Gaza StripRami J Al Sallout, Fadel A SharifBasic and Clinical Neuroscience|January 2, 2023
Investigating the Cocaine-induced Reduction of Potassium Current on the Generation of Action Potentials Using a Computational ModelHadi Borjkhani, Mehdi Borjkhani, Morteza A SharifOptics Express|September 13, 2019
Deep color reconstruction for a sparse color sensorS M A Sharif, Yong Ju JungCase Reports in Medicine|April 3, 2019
Partial Trisomy of Chromosome 13 with a Novel Translocation (8 ; 13) and Unique Clinical Presentation in a Palestinian InfantAllam Abuhamda, Aymen Elsous, Fadel A SharifFrontiers in Computational Neuroscience|March 11, 2026
Population-level neural rejuvenation dynamics in addiction: a computational framework for understanding developmental plasticity reactivationMehdi Borjkhani, Hadi Borjkhani, Morteza A SharifPlos One|June 1, 2026
Magnesium neuroprotection in retinal ganglion cells: A computational study of frequency-dependent therapeutic windows and intervention timingMehdi Borjkhani, Hadi Borjkhani, Morteza A SharifClinical Pharmacology and Therapeutics|May 18, 2017
Negative Cardiovascular Consequences of Small Molecule ImmunosuppressantsH A Chakkera, A Sharif, B KaplanPageof 40